Y, S., S, N., M, N., H, T., & Y, K. (2015). Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Shimizu, Nakakura S, Nishiyama M, Tabuchi H, et Kiuchi Y. Efficiency, Safety, and Patient Preference of Switching from Dorzolamide 1%/timolol 0.5% to Brinzolamide 1%/timolol 0.5% While Maintaining the Prostaglandin F2α Analog. Dove Medical Press, 2015.
Style de citation MLA (8e éd.)Y, Shimizu, et al. Efficiency, Safety, and Patient Preference of Switching from Dorzolamide 1%/timolol 0.5% to Brinzolamide 1%/timolol 0.5% While Maintaining the Prostaglandin F2α Analog. Dove Medical Press, 2015.